The U.S. Food and Drug Administration is giving the seafood industry two more months to comment on a draft guidance on ...
The recent Food and Drug Administration approval of two new gene therapies brings the promise of a cure. Roughly 100,000 Americans, most of whom are Black, are living with sickle cell disease.
The U.K. government has approved new rules for hemp cultivation designed to ease growing the crop for farmers and spur new ...
A lobbying effort led in part by religious groups has state lawmakers considering two different measures that would legalize ...
Weight-loss Drug Zepbound Eases Sleep Apnea in Company Trials By Robin Foster HealthDay Reporter WEDNESDAY, April 17, 2024 (HealthDay News) -- Zepbound, one of the wildly popular weight-loss drugs ...
Recreational marijuana remains illegal in about half of the U.S. as products that deliver a similar high gain popularity in ...
Pricing: Weight loss medications can cost as low as $199 per monthly (compound Semaglutide), or as much as $1,000 per month ...
20 billion US dollars is the estimated pharmaceutical market growth and reach in the GCC region.
Some have already described the new alcohol restrictions as a band-aid solution to a complex problem in the South Australian ...
Roughly 100,000 Americans, most of whom are Black, are living with sickle cell disease. The recent Food and Drug Administration approval of two new gene therapies brings the promise of a cure.
First approved to treat obesity by the U.S. Food and Drug Administration last November, Zepbound's power was significant: It reduced sleep apnea severity by nearly two-thirds in patients ...